MLSS icon

Milestone Scientific

0.6072 USD
+0.0211
3.60%
At close Aug 26, 4:00 PM EDT
1 day
3.60%
5 days
-0.13%
1 month
24.63%
3 months
-39.27%
6 months
-35.58%
Year to date
-35.41%
1 year
-39.28%
5 years
-62.98%
10 years
-77.09%
 

About: Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.

Employees: 17

0
Funds holding %
of 7,433 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

600% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

17% more funds holding

Funds holding: 29 [Q1] → 34 (+5) [Q2]

0.39% more ownership

Funds ownership: 5.37% [Q1] → 5.76% (+0.39%) [Q2]

26% less capital invested

Capital invested by funds: $3.9M [Q1] → $2.88M (-$1.02M) [Q2]

Research analyst outlook

We haven’t received any recent analyst ratings for MLSS.

Financial journalist opinion

Based on 4 articles about MLSS published over the past 30 days

Neutral
GlobeNewsWire
1 week ago
Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025
Expands senior leadership team and board of directors to support next phase of growth Expands senior leadership team and board of directors to support next phase of growth
Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025
Neutral
GlobeNewsWire
1 week ago
Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
ROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:00 AM Eastern Time on Friday, August 15th, 2025, to discuss the company's financial results for the second quarter ended June 30, 2025, as well as the company's corporate progress and other developments.
Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
Neutral
GlobeNewsWire
2 weeks ago
Milestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and Marketing
ROSELAND. N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Jason Papes as Senior Vice President, Global Head of Sales and Marketing, effective immediately.
Milestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and Marketing
Neutral
GlobeNewsWire
3 weeks ago
Milestone Scientific Appoints Eric C. Hines as Chief Executive Officer
Seasoned executive with proven track record driving growth and building customer focused teams to lead Milestone's next phase of commercial execution Seasoned executive with proven track record driving growth and building customer focused teams to lead Milestone's next phase of commercial execution
Milestone Scientific Appoints Eric C. Hines as Chief Executive Officer
Neutral
GlobeNewsWire
1 month ago
Milestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey
ROSELAND, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the initiation of commercial sales of its CompuFlo® Epidural System and related disposables at The Painless Center, located in Tenafly, New Jersey.
Milestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey
Neutral
GlobeNewsWire
3 months ago
Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
Brings Proven Commercial Leadership, Reimbursement Expertise, and Global Market Insight to Support Next Phase of Growth Across Medical and Dental Segments Brings Proven Commercial Leadership, Reimbursement Expertise, and Global Market Insight to Support Next Phase of Growth Across Medical and Dental Segments
Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
Neutral
GlobeNewsWire
3 months ago
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025
ROSELAND, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and reported financial results for the first quarter ended March 31, 2025.
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025
Neutral
GlobeNewsWire
4 months ago
Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey
Dr. Roman Kosiborod, DO to Utilize CompuFlo® for Enhanced Precision in Pain Management Procedures Dr. Roman Kosiborod, DO to Utilize CompuFlo® for Enhanced Precision in Pain Management Procedures
Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey
Neutral
GlobeNewsWire
6 months ago
Milestone Scientific Expands Adoption of CompuFlo® Epidural System with Commercial Rollout at Pain Doctors Medical LLC
Dr. Ilana Etelzon Integrates CompuFlo® Epidural System into Practice Following Positive Clinical Experience Dr. Ilana Etelzon Integrates CompuFlo® Epidural System into Practice Following Positive Clinical Experience
Milestone Scientific Expands Adoption of CompuFlo® Epidural System with Commercial Rollout at Pain Doctors Medical LLC
Neutral
GlobeNewsWire
7 months ago
Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder Dhillon
Reports Expanding Adoption of CompuFlo® Epidural System Following Previously Announced Medicare Price Assignment Reports Expanding Adoption of CompuFlo® Epidural System Following Previously Announced Medicare Price Assignment
Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder Dhillon
Charts implemented using Lightweight Charts™